Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine - PubMed

Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine

S Tsubuki et al. J Biochem. 1996 Mar.

Free article

Abstract

To explore membrane-permeable synthetic inhibitors that discriminate between endogenous calpain and proteasome in cells, we examined the inhibition of profiles against calpain and proteasome in vitro and in vivo of peptidyl aldehydes possessing di-leucine and tri-leucine. The tripeptide aldehyde benzyloxycarbonyl-leucyl-leucinal (ZLLLal) strongly inhibited calpain and proteasome activities in vitro. The concentration required for 50% inhibition (IC50) of the casein-degrading activity of calpain was 1.25 microM, and the IC50s for the succinyl-leucyl-leucyl-valyl-tyrosine-4-methylcoumaryl-7-amide (Suc-LLVY-MCA)- and benzyloxycarbonyl-leucyl-leucyl-leucine-4-methylcoumaryl -7-amide (ZLLL-MCA)-degrading activities of proteasome were 850 and 100 nM, respectively. On the other hand, the synthetic dipeptide aldehyde benzyloxycarbonyl-leucyl-leucinal (ZLLal) strongly inhibited the casein degrading activity of calpain (IC50 1.20 microM), but the inhibition of proteasome was weak (IC50S for SucLLVY-MCA- and ZLLL-MCA-degrading activities were 120 and 110 microM, respectively). Thus, while calpain was inhibited by similar concentrations of ZLLal and ZLLLal, the inhibitory potencies of ZLLLal against the ZLLL-MCA- and Suc-LLVY-MCA-degrading activities in proteasome were 1,100 and 140 times stronger than those of ZLLal, respectively. To evaluate the effectiveness of these inhibitors on intracellular proteasome, the induction of neurite outgrowth in PC12 cells caused by proteasome inhibition was examined. ZLLLal and ZLLal initiated neurite outgrowth with optimal concentrations of 20 nM and 10 microM, respectively, again showing a big difference in the effective concentrations for the proteasome inhibition as in vitro. As for the effect on intracellular calpain, the concentration of ZLLLal and ZLLal required for the inhibition of the autolytic activation of calpain in rabbit erythrocytes were 100 and 100 microM or more, respectively. The almost equal inhibitory potencies of ZLLLal and ZLLal were in agreement with the inhibition of calpain in vitro. These differential effects of inhibitors against calpain and proteasome are potentially useful for identifying the functions of calpain and proteasome in cell physiology and pathology.

Similar articles

• Proteasome inhibitors which induce neurite outgrowth from PC12h cells cause different subcellular accumulations of multi-ubiquitin chains.

  Ohtani-Kaneko R, Takada K, Iigo M, Hara M, Yokosawa H, Kawashima S, Ohkawa K, Hirata K. Ohtani-Kaneko R, et al. Neurochem Res. 1998 Nov;23(11):1435-43. doi: 10.1023/a:1020763009488. Neurochem Res. 1998. PMID: 9814555

• Purification and characterization of a Z-Leu-Leu-Leu-MCA degrading protease expected to regulate neurite formation: a novel catalytic activity in proteasome.

  Tsubuki S, Kawasaki H, Saito Y, Miyashita N, Inomata M, Kawashima S. Tsubuki S, et al. Biochem Biophys Res Commun. 1993 Nov 15;196(3):1195-201. doi: 10.1006/bbrc.1993.2378. Biochem Biophys Res Commun. 1993. PMID: 8250877

• Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome.

  Mellgren RL. Mellgren RL. J Biol Chem. 1997 Nov 21;272(47):29899-903. doi: 10.1074/jbc.272.47.29899. J Biol Chem. 1997. PMID: 9368065

• Synthetic inhibitors of the multicatalytic proteinase complex (proteasome).

  Wilk S, Figueiredo-Pereira ME. Wilk S, et al. Enzyme Protein. 1993;47(4-6):306-13. doi: 10.1159/000468688. Enzyme Protein. 1993. PMID: 7697128

• Role of calpain and its inhibitors in tissue degeneration and neuroprotection in spinal cord injury.

  Banik NL, Matzelle D, Gantt-Wilford G, Hogan EL. Banik NL, et al. Ann N Y Acad Sci. 1997 Oct 15;825:120-7. doi: 10.1111/j.1749-6632.1997.tb48421.x. Ann N Y Acad Sci. 1997. PMID: 9369980 Review. No abstract available.

Cited by

• Neisseria gonorrhoeae-derived heptose elicits an innate immune response and drives HIV-1 expression.

  Malott RJ, Keller BO, Gaudet RG, McCaw SE, Lai CC, Dobson-Belaire WN, Hobbs JL, St Michael F, Cox AD, Moraes TF, Gray-Owen SD. Malott RJ, et al. Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10234-9. doi: 10.1073/pnas.1303738110. Epub 2013 Jun 3. Proc Natl Acad Sci U S A. 2013. PMID: 23733950 Free PMC article.

• Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration.

  Hwang JY, Lee J, Oh CK, Kang HW, Hwang IY, Um JW, Park HC, Kim S, Shin JH, Park WY, Darnell RB, Um HD, Chung KC, Kim K, Oh YJ. Hwang JY, et al. Cell Death Dis. 2016 Jun 2;7(6):e2240. doi: 10.1038/cddis.2016.151. Cell Death Dis. 2016. PMID: 27253404 Free PMC article.

• Proteasome inhibitors: an expanding army attacking a unique target.

  Kisselev AF, van der Linden WA, Overkleeft HS. Kisselev AF, et al. Chem Biol. 2012 Jan 27;19(1):99-115. doi: 10.1016/j.chembiol.2012.01.003. Chem Biol. 2012. PMID: 22284358 Free PMC article. Review.

• Inhibition of the ubiquitin-proteasome system reduces the abundance of pyruvate dehydrogenase kinase 1 in cultured myotubes.

  Kociper B, Škorja Milić N, Ogrizek I, Miš K, Pirkmajer S. Kociper B, et al. J Muscle Res Cell Motil. 2024 Sep;45(3):155-169. doi: 10.1007/s10974-024-09679-3. Epub 2024 Jul 31. J Muscle Res Cell Motil. 2024. PMID: 39080182 Free PMC article.

• Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-kappaB.

  Tripathi AK, Sullivan DJ, Stins MF. Tripathi AK, et al. Infect Immun. 2006 Jun;74(6):3262-70. doi: 10.1128/IAI.01625-05. Infect Immun. 2006. PMID: 16714553 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • J-STAGE, Japan Science and Technology Information Aggregator, Electronic
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program